Sessa Capital (Master), L.P.

Insider Reports History

Location
888 Seventh Avenue, 30 Th Floor, New York, NY
Signature
/s/ John Petry, for Sessa Capital (Master), L.P., By: Sessa Capital GP, LLC, its general partner, By: John Petry, as manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sessa Capital (Master), L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Common Stock 2.2M $3.85M $1.75 Sep 29, 2025 Direct
SAB Biotherapeutics, Inc. Director Series B Convertible Preferred Stock 211K Sep 29, 2025 Direct
SAB Biotherapeutics, Inc. Director Warrants (right to buy) 114K Jul 22, 2025 Direct
Provention Bio, Inc. 10%+ Owner Common Stock 0 $24.32 Apr 27, 2023 Direct
Provention Bio, Inc. 10%+ Owner Warrants 0 Apr 14, 2023 Direct

Insider Reports Filed by Sessa Capital (Master), L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Sep 29, 2025 2 $3.05M 4 Oct 1, 2025 Director
SABS SAB Biotherapeutics, Inc. Jul 22, 2025 3 $0 4 Jul 24, 2025 Director
SABS SAB Biotherapeutics, Inc. Nov 24, 2023 3 -$2.89M 4 Nov 28, 2023 Director
SABS SAB Biotherapeutics, Inc. Nov 10, 2023 1 $13.3M 4/A Nov 15, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 23, 2023 2 $16.3M 4 Oct 24, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 2, 2023 0 $0 3 Oct 10, 2023 Director
PRVB Provention Bio, Inc. Apr 27, 2023 1 $0 4 Apr 28, 2023 10%+ Owner
PRVB Provention Bio, Inc. Apr 20, 2023 2 $0 4 Apr 24, 2023 10%+ Owner
PRVB Provention Bio, Inc. Apr 14, 2023 3 -$14 4 Apr 18, 2023 10%+ Owner
PRVB Provention Bio, Inc. Mar 31, 2023 2 $0 4 Apr 4, 2023 10%+ Owner
PRVB Provention Bio, Inc. Jan 18, 2023 1 -$28.2M 4 Jan 20, 2023 10%+ Owner
PRVB Provention Bio, Inc. Jul 7, 2022 0 $0 3 Jul 11, 2022 10%+ Owner